Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT06684600 · RECRUITING
Trial details
- NCT number
- NCT06684600
- Sponsor
- Peking University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2025-10-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.